If I have for example 5 to 10 samples of a few different developmental time periods that I want to compare gene expression, what should be my pick for accuracy? Splicing info is interesting but not a deal breaker.
Unconfigured Ad
Collapse
X
-
Should I choose RNA-seq or Microarray for my future experiment?
Any need for antibodies, viral antigens, innovative diagnostic components and critical assay reagents, please visit here. -
-
Depends on your experiment and your situation! Do you have access to RNA-seq and/or microarray in house or will you outsource? Is there a bioinformatics group who can at least do the sequence alignment and read counting part of the analysis for you? Personally I can't see why I'd ever do microarray again because I can get RNA-seq done in house cheaply and easily, there's a pipeline to do the alignment, and I've analysed it before. That's before you consider the benefits of dynamic range, sensitivity etc. OTOH, the benefit of microarray is that you get nice easy CEL files back and the analysis is easy.
Take care of your experimental design... Replicates are important to estimate within-group variance. Don't bother doing paired end seq if you just want to measure gene level expression, single end is cheaper per read and so more cost effective. No need to go above 15-20M reads per sample unless you're really interested in low expressers, spend the money on more reps instead.
Comment
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Yesterday, 11:13 AM
|
0 responses
19 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 11:13 AM
|
||
|
Started by SEQadmin2, Yesterday, 10:48 AM
|
0 responses
18 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 10:48 AM
|
||
|
Started by SEQadmin2, 10-15-2026, 10:52 AM
|
0 responses
36 views
0 reactions
|
Last Post
by SEQadmin2
10-15-2026, 10:52 AM
|
||
|
Started by SEQadmin2, 10-14-2026, 05:39 AM
|
0 responses
42 views
0 reactions
|
Last Post
by SEQadmin2
10-14-2026, 05:39 AM
|
Comment